PLIANT THERAPEUTICS, INC. (PLRX) Return on equity 2020–2025
PLIANT THERAPEUTICS, INC. (PLRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
82.4%FY2025 · since FY2020: -14.7% → 82.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 82.4% | +13.2 pp |
| FY2024 | 69.2% | +35.1 pp |
| FY2023 | 34.1% | +73.4 pp |
| FY2022 | -39.4% | +9.5 pp |
| FY2021 | -48.9% | -34.2 pp |
| FY2020 | -14.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice